GlassScriptPhysician profile
Monica Sharma
NPI 1477710788
$8,138.73
in general payments reported to CMS, 2019-2025
17 companies · $1,085 in 2025
The $1,085 reported for 2025 was more than what 80% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,180 · 2020: $1,288 · 2021: $1,598 · 2022: $1,101 · 2023: $824 · 2024: $1,064 · 2025: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,961 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,961.48 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $3,059.67 | 2019-2025 | Biktarvy |
| Merck Sharp & Dohme LLC | $894.59 | 2019-2025 | Pifeltro, Delstrigo, Dificid |
| Viiv Healthcare Company | $859.09 | 2019-2025 | Rukobia, Apretude, Dovato |
| Janssen Biotech, INC. | $622.19 | 2019-2022 | |
| Melinta Therapeutics, LLC | $611.35 | 2019-2025 | Kimyrsa, Orbactiv, Rezzayo |
| Abbvie INC. | $442.07 | 2019-2025 | Avycaz, Mavyret |
| Napo Pharmaceuticals INC | $360.50 | 2020-2025 | Mytesi |
| Janssen Products, LP | $280.47 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $243.13 | 2019-2025 | Nuzyra |
| Theratechnologies INC. | $242.74 | 2019-2025 | Egrifta, Trogarzo |
| Shionogi INC | $232.50 | 2019-2025 | Fetroja |
| Nabriva Therapeutics, Plc | $64.99 | 2020-2021 | |
| Allergan, INC. | $60.99 | 2019-2020 | |
| Astellas Pharma US INC | $60.97 | 2023-2024 | Cresemba |
| Cumberland Pharmaceuticals, INC. | $53.53 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $30.30 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.